Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Williams

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Controlled Clinical Trials|December 1, 1987
Recruitment experience in the Nocturnal Oxygen Therapy TrialG W Williams, S M Snedecor, D L DeMets
Controlled Clinical Trials|June 1, 1982
A case report of data monitoring experience: the nocturnal oxygen therapy trialD L DeMets, G W Williams, B W Brown
American Journal of Clinical Pathology|October 1, 1980
The distribution of selected hematology measurements in the CAP surveyG W Williams, T L Burns, M A Schork
Circulation|September 1, 1985
Hemodynamic performance of the Carpentier-Edwards pericardial valve in the aortic position in vivoD M Cosgrove, B W Lytle, G W Williams
Physiology & Behavior|October 1, 1992
The effects of olfactory bulbectomy and chronic psychosocial stress on serum glucocorticoids and sexual behavior in female ratsG W Williams, M Y McGinnis, A R Lumia
The Journal of Pharmacy and Pharmacology|August 24, 1999
[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptorN A Sharif, T L Davis, G W Williams
Trends in Genetics : TIG|June 20, 2000
GHOST: a gene homology online search toolV A Curwen, G W Williams, J B Bard
European Journal of Pharmacology|December 13, 2001
Bimatoprost and its free acid are prostaglandin FP receptor agonistsN A Sharif, G W Williams, C R Kelly
Neurochemical Research|June 1, 1995
Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classesN A Sharif, G W Williams, L M DeSantis
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
Analyte stability in clinical chemistry quality control materialsN S Lawson, G T Haven, G W Williams
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Controlled Clinical Trials|December 1, 1987
Recruitment experience in the Nocturnal Oxygen Therapy TrialG W Williams, S M Snedecor, D L DeMets
Controlled Clinical Trials|June 1, 1982
A case report of data monitoring experience: the nocturnal oxygen therapy trialD L DeMets, G W Williams, B W Brown
American Journal of Clinical Pathology|October 1, 1980
The distribution of selected hematology measurements in the CAP surveyG W Williams, T L Burns, M A Schork
Circulation|September 1, 1985
Hemodynamic performance of the Carpentier-Edwards pericardial valve in the aortic position in vivoD M Cosgrove, B W Lytle, G W Williams
Physiology & Behavior|October 1, 1992
The effects of olfactory bulbectomy and chronic psychosocial stress on serum glucocorticoids and sexual behavior in female ratsG W Williams, M Y McGinnis, A R Lumia
The Journal of Pharmacy and Pharmacology|August 24, 1999
[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptorN A Sharif, T L Davis, G W Williams
Trends in Genetics : TIG|June 20, 2000
GHOST: a gene homology online search toolV A Curwen, G W Williams, J B Bard
European Journal of Pharmacology|December 13, 2001
Bimatoprost and its free acid are prostaglandin FP receptor agonistsN A Sharif, G W Williams, C R Kelly
Neurochemical Research|June 1, 1995
Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classesN A Sharif, G W Williams, L M DeSantis
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
Analyte stability in clinical chemistry quality control materialsN S Lawson, G T Haven, G W Williams
Pageof 10